Compounds > phepromaron
Page last updated: 2024-11-13

phepromaron

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

phepromaron: Russian drug [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54682128
SCHEMBL ID11700323
MeSH IDM0045961

Synonyms (23)

Synonym
CBKINASE1_012849
OPREA1_012979
CBKINASE1_000449
OPREA1_524213
phepromaron
3-(alpha-phenyl-beta-propionylethyl)-4-oxycoumarin
fepromaron
2h-1-benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylpentyl)-
CBDIVE_000146
CBDIVE_003403
CBDIVE_003443
CBDIVE_002886
15620-34-5
unii-x33o8v6kue
x33o8v6kue ,
SCHEMBL11700323
fepromaron [who-dd]
phepromarin
coumarin, 4-hydroxy-3-(.alpha.-(2-oxobutyl)benzyl)-
2-hydroxy-3-(3-oxo-1-phenylpentyl)-4h-1-benzopyran-4-one
DTXSID90935392
Q27293495
4-hydroxy-3-(3-oxo-1-phenylpentyl)chromen-2-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

\N \N \N \N \N
TimeframeStudies, This Drug (%)All Drugs %
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
ConditionIndicatedRelationship StrengthStudiesTrials